REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,061,000 | -57.7% | 100,000 | -40.5% | 0.41% | -49.4% |
| Q2 2021 | $23,798,000 | -40.3% | 168,150 | -58.0% | 0.81% | -9.0% |
| Q1 2021 | $39,880,000 | -35.5% | 400,000 | -20.0% | 0.89% | -39.6% |
| Q4 2020 | $61,810,000 | +41.0% | 500,000 | +11.1% | 1.47% | -12.8% |
| Q3 2020 | $43,839,000 | -29.8% | 450,000 | +12.5% | 1.69% | -29.2% |
| Q2 2020 | $62,408,000 | -41.4% | 400,000 | -45.7% | 2.38% | -51.9% |
| Q1 2020 | $106,408,000 | -51.2% | 737,206 | -30.9% | 4.94% | -43.2% |
| Q4 2019 | $218,005,000 | +231.2% | 1,066,400 | +30.1% | 8.70% | +117.1% |
| Q3 2019 | $65,819,000 | -13.5% | 819,769 | +1.7% | 4.01% | -8.3% |
| Q2 2019 | $76,060,000 | +44.7% | 806,150 | +31.1% | 4.37% | +23.0% |
| Q1 2019 | $52,564,000 | +39.0% | 615,000 | -8.8% | 3.55% | +15.7% |
| Q4 2018 | $37,825,000 | -29.9% | 674,251 | +2.2% | 3.07% | -12.4% |
| Q3 2018 | $53,962,000 | +242.9% | 660,000 | +46.7% | 3.51% | +201.0% |
| Q2 2018 | $15,737,000 | +70.5% | 450,000 | 0.0% | 1.16% | +69.3% |
| Q1 2018 | $9,230,000 | +63.0% | 450,000 | +125.0% | 0.69% | +16.0% |
| Q4 2017 | $5,664,000 | -53.1% | 200,000 | -48.5% | 0.59% | -72.2% |
| Q3 2017 | $12,085,000 | – | 388,574 | – | 2.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |